Clinico-microbiological diagnosis of chronic pulmonary aspergillosis among high-risk patients at a tertiary care center in India
Abstract
Background: Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality among high-risk patients, particularly those with structural lung disease or immunosuppressive conditions. Conventional diagnostic methods, including fungal culture, have limited sensitivity, underscoring the need for more reliable adjunctive diagnostic tools, such as galactomannan (GM) testing in bronchoalveolar lavage (BAL). Objectives: To evaluate the clinico-microbiological profile of IPA in high-risk patients and to assess the diagnostic performance of BAL GM testing relative to conventional fungal culture. Materials and Methods: This retrospective study included BAL samples from high-risk patients with suspected pulmonary aspergillosis at a tertiary care center in India. All samples underwent potassium hydroxide (KOH) wet mount, fungal culture, and BAL GM enzyme-linked immunosorbent assay. We classified patients as having proven, probable, or possible IPA according to the European Organization for Research and Treatment of Cancer/Mycoses Study Group Education and Research Consortium criteria. Results: Of 123 patients with chronic pulmonary infections, 62.5% were classified as probable IPA, 35.0% as possible IPA, and 2.5% as proven IPA. BAL GM positivity (optical density index ≥ 1.0) was observed in 56.25% of patients, whereas fungal culture was positive in only 20.0%. Among patients with probable IPA, BAL GM was positive in 44%, compared with a culture positivity rate of 30%. Aspergillus flavus was the most frequently isolated species (16%), followed by Aspergillus fumigatus (8%) and Aspergillus niger (4%). Tuberculosis (28%) and chronic obstructive pulmonary disease (26%) were the most common predisposing conditions. BAL GM positivity was significantly associated with the diagnostic category (P < 0.001) and with fungal culture positivity (P = 0.03). Conclusion: BAL GM testing demonstrated superior diagnostic performance compared with conventional fungal culture and is a valuable adjunctive tool for diagnosing pulmonary aspergillosis in high-risk patients.
Related
- Establishment of Aspergillus fumigatus-specific IgG cut-off level for diagnosis of chronic pulmonary aspergillosis in the Iranian population
- Clinical and Microbiological Characteristics of Patients with Desulfovibrio spp. Bacteremia in a Japanese Tertiary Hospital: A Case Series
- Influenza A-associated pulmonary aspergillosis in critically ill patients in the post-COVID-19 era: a multicenter cohort study from China
- Microbiological Profile and Antimicrobial Resistance Patterns Among Orthopedic Patients at a Tertiary Care Centre in Uttarakhand, India
- A novel predictive tool for pulmonary aspergillosis in critically ill patients with viral pneumonia: a multi-center, ambispective cohort study
BibTeX
@article{garg2026clinicomicrobiological,
title = {{Clinico-microbiological diagnosis of chronic pulmonary aspergillosis among high-risk patients at a tertiary care center in India}},
author = {Parul Garg and Sushil Singhal and Arti Agrawal and Sanjeev Singhal and Deeksha Agrawal and Pragya Shakya},
journal = {MGM Journal of Medical Sciences},
year = {2026},
month = jul,
doi = {10.4103/mgmj.mgmj_104_26},
url = {https://doi.org/10.4103/mgmj.mgmj_104_26},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Clinico-microbiological diagnosis of chronic pulmonary aspergillosis among high-risk patients at a tertiary care center in India
AU - Parul Garg
AU - Sushil Singhal
AU - Arti Agrawal
AU - Sanjeev Singhal
AU - Deeksha Agrawal
AU - Pragya Shakya
PY - 2026
DA - 2026/07/01
JO - MGM Journal of Medical Sciences
DO - 10.4103/mgmj.mgmj_104_26
UR - https://doi.org/10.4103/mgmj.mgmj_104_26
AB - Background: Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality among high-risk patients, particularly those with structural lung disease or immunosuppressive conditions. Conventional diagnostic methods, including fungal culture, have limited sensitivity, underscoring the need for more reliable adjunctive diagnostic tools, such as galactomannan (GM) testing in bronchoalveolar lavage (BAL). Objectives: To evaluate the clinico-microbiological profile of IPA in high-risk patients and to assess the diagnostic performance of BAL GM testing relative to conventional fungal culture. Materials and Methods: This retrospective study included BAL samples from high-risk patients with suspected pulmonary aspergillosis at a tertiary care center in India. All samples underwent potassium hydroxide (KOH) wet mount, fungal culture, and BAL GM enzyme-linked immunosorbent assay. We classified patients as having proven, probable, or possible IPA according to the European Organization for Research and Treatment of Cancer/Mycoses Study Group Education and Research Consortium criteria. Results: Of 123 patients with chronic pulmonary infections, 62.5% were classified as probable IPA, 35.0% as possible IPA, and 2.5% as proven IPA. BAL GM positivity (optical density index ≥ 1.0) was observed in 56.25% of patients, whereas fungal culture was positive in only 20.0%. Among patients with probable IPA, BAL GM was positive in 44%, compared with a culture positivity rate of 30%. Aspergillus flavus was the most frequently isolated species (16%), followed by Aspergillus fumigatus (8%) and Aspergillus niger (4%). Tuberculosis (28%) and chronic obstructive pulmonary disease (26%) were the most common predisposing conditions. BAL GM positivity was significantly associated with the diagnostic category (P < 0.001) and with fungal culture positivity (P = 0.03). Conclusion: BAL GM testing demonstrated superior diagnostic performance compared with conventional fungal culture and is a valuable adjunctive tool for diagnosing pulmonary aspergillosis in high-risk patients.
SN - 2347-7946
SN - 2347-7962
ER -